Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on: March 12,2024 19

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on:March 12,2024 19

Factors predict low BMD in pediatric blood cancer survivors

Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 inCancer.Hadley M. Bloomhardt, M.D., from the Yale School of

Updated on: May 11,2024 8

Factors predict low BMD in pediatric blood cancer survivors

Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 inCancer.Hadley M. Bloomhardt, M.D., from the Yale School of

Updated on:May 11,2024 8

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t

Updated on: February 18,2024 17

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t

Updated on:February 18,2024 17

Researchers discover a new cancer-driving mutation in 'dark matter' of the cancer genome

by Ontario Institute for Cancer ResearchCredit: CC0 Public DomainAn Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome,

Updated on: June 04,2024 4

Researchers discover a new cancer-driving mutation in 'dark matter' of the cancer genome

by Ontario Institute for Cancer ResearchCredit: CC0 Public DomainAn Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome,

Updated on:June 04,2024 4

Protein linked to aggressive skin cancer

by Lund UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Almost 300,000 people worldwide develop malignan

Updated on: May 07,2024 16

Protein linked to aggressive skin cancer

by Lund UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Almost 300,000 people worldwide develop malignan

Updated on:May 07,2024 16

Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on: June 04,2024 8

Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on:June 04,2024 8

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

Updated on: November 22,2024 0

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

Updated on:November 22,2024 0

Researchers discover the Achilles' heel of an aggressive brain cancer

by University of HelsinkiGlioblastoma cells (red) are known to invade the brain (blue). Figure shows patient-derived glioblastoma in murine brain treated with saline (control). Credit: Laakkonen

Updated on: June 22,2024 6

Researchers discover the Achilles' heel of an aggressive brain cancer

by University of HelsinkiGlioblastoma cells (red) are known to invade the brain (blue). Figure shows patient-derived glioblastoma in murine brain treated with saline (control). Credit: Laakkonen

Updated on:June 22,2024 6

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Updated on: July 02,2024 7

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Updated on:July 02,2024 7

Immunotherapy plus an investigational cancer drug improves anti-tumor effects

by Duke University Medical CenterCredit: Pixabay/CC0 Public DomainAn investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific k

Updated on: March 06,2024 18

Immunotherapy plus an investigational cancer drug improves anti-tumor effects

by Duke University Medical CenterCredit: Pixabay/CC0 Public DomainAn investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific k

Updated on:March 06,2024 18

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on: January 30,2024 16

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on:January 30,2024 16

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on: September 07,2024 0

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on:September 07,2024 0